Century Therapeutics IPSC
NASDAQ IPSC
$1.71 +0.06 (+3.33%)
As of: Sep 30, 2026 · 3:52 PM EDT

Century Therapeutics (IPSC) Preferred Stock Liabilities (2020 - 2021)

Updated

Century Therapeutics' Preferred Stock Liabilities was $339.39 million in Q1 2021, up 134.3% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Preferred Stock Liabilities at Century Therapeutics came in at $144.84 million.

  • Per Business Quant data, IPSC's Preferred Stock Liabilities in the three quarters before Q1 2021 was $144.84 million (Q4 2020), $179.83 million (Q3 2020) and $179.83 million (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Century Therapeutics 297.90 Mn -206.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 339.39 Mn
Dec 31, 2020 144.84 Mn
Sep 30, 2020 179.83 Mn
Jun 30, 2020 179.83 Mn
API Access

Century Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=IPSC&period=max&api_key=YOUR_API_KEY